← Back to catalogue

Provox ActiValve Lubricant

FDA UDI

Class II (US FDA UDI)

by Atos Medical Inc.

Identity

Trade Name
Provox ActiValve Lubricant FDA UDI
Generic Name
Tracheoesophageal speech valve, indwelling FDA UDI
Device Name
Provox ActiValve Lubricant shall be applied as a thin film on the inner lumen of Provox ActiValve voice prosthesis to help prevent occasional temporary blockage of the valve. FDA UDI
Model / Reference
7149 FDA UDI
Description
Provox ActiValve Lubricant shall be applied as a thin film on the inner lumen of Provox ActiValve voice prosthesis to help prevent occasional temporary blockage of the valve. FDA UDI

Identifiers

Catalog Number
7149 FDA UDI
Primary DI / UDI-DI
07331791000515 FDA UDI
510(k) Number
K092593 FDA UDI
FDA Product Code
EWL FDA UDI
GMDN Term
Tracheoesophageal speech valve, indwelling FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
874.3730 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI
MRI Safety
MR Unsafe FDA UDI

Category: Tracheoesophageal speech valve, indwelling

Provox ActiValve Lubricant by Atos Medical Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Tracheoesophageal speech valve, indwelling.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Atos Medical Inc.

Sources (1)

  • FDA UDI ccf50c84-3d0a-47a8-a1c2-b10e3654ed54 37 fields · synced May 29, 2026